N-3 Fatty acids and prostate cancer risk

British Journal of Nutrition

Volumn 108, Issue 9, 2012, Pages 1721-

  Brasky, Theodore M ^a   Crowe, Francesca L ^b   Kristal, Alan R ^c  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

CANCER GRADING; CANCER PREVENTION; CANCER RISK; LETTER; PROSTATE CANCER; RISK REDUCTION;

ANIMALS; ANTICARCINOGENIC AGENTS; DIET; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASMS;

EID: 84870023798     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512003431     Document Type: Letter

References (5)

1. Gerber M (2012) Omega-3 fatty acids and cancers: a systematic update of epidemiological studies. Br J Nutr 107, Suppl. 2, S228-S239.
2. Crowe FL, Allen NE, Appleby PN, et al. (2008) Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 88, 1353-1363.
3. Brasky TM, Till C, White E, et al. (2011) Serum phospholipid fatty acids and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Am J Epidemiol 173, 1429-1439.
4. Park SY, Wilkens LR, Henning SM, et al. (2009) Circulating fatty acids and prostate cancer risk in a nested case-control study: the Multiethnic Cohort. Cancer Causes Control 20, 211-223.
5. Moyad MA (2005) An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: parts I & II. Urol Oncol 23, 28-48.